Long‐term strength and functional status in inclusion body myositis and identification of trajectory subgroups
Open Access
- 5 March 2020
- journal article
- research article
- Published by Wiley in Muscle & Nerve
- Vol. 62 (1) , 76-82
Abstract
Introduction: Objective information on longitudinal disease progression in inclusion body myositis (IBM) is lacking.Methods: Longitudinal dynamometry and functional status data were collated from a cohort of IBM patients. Annual change was calculated by means of linear modeling. Trajectories of change in grip, knee extension, IBM Functional Rating Scale (IBM‐FRS) and Neuromuscular Symptom Score (NSS) were identified by means of latent growth mixture modeling.Results: Data were collated from 75 IBM patients (348 person‐years follow‐up). Annual strength loss was greatest for pinch (−10%) and knee extension (−4%). Functional deterioration was greatest for males. Three distinct trajectory groups were identified. Rapid deterioration trajectory for grip strength was associated with younger diagnosis age. Rapid deterioration for knee extension strength was associated with older age of diagnosis.Discussion: This study has quantified strength change in IBM and identified distinct trajectory groups, which will aid prognostication and stratification for inclusion into future clinical trials.Keywords
Funding Information
- Medical Research Council Canada (MR/N003322/1)
- Manchester Biomedical Research Centre
- Versus Arthritis (21993)
This publication has 25 references indexed in Scilit:
- Autoantibodies to cytosolic 5′‐nucleotidase 1A in inclusion body myositisAnnals of Neurology, 2012
- Quadriceps strength is a sensitive marker of disease progression in sporadic inclusion body myositisNeuromuscular Disorders, 2012
- Group-Based Trajectory Modeling in Clinical ResearchAnnual Review of Clinical Psychology, 2010
- Inclusion body myositisNeuromuscular Disorders, 2010
- Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositisBrain, 2009
- Inclusion body myositis functional rating scale: A reliable and valid measure of disease severityMuscle & Nerve, 2008
- Deciding on the Number of Classes in Latent Class Analysis and Growth Mixture Modeling: A Monte Carlo Simulation StudyStructural Equation Modeling: A Multidisciplinary Journal, 2007
- Treatment of inclusion-body myositis with IVIgNeurology, 1997
- Inclusion body myositis and myopathiesAnnals of Neurology, 1995
- Treatment of inclusion‐body myositis with high‐dose intravenous immunoglobulinNeurology, 1993